Join our community of smart investors

Hvivo valuation under cosh

Shares in the early-stage biotech group have dropped more than 50 per cent in the past two weeks
April 12, 2018

The problem with major institutional presence in small-cap companies is that share trades are few and far between. This means that when someone is either selling or buying, the share price movement is magnified. Hvivo (HVO) is increasingly finding this to its cost. The share price more than halved during the two weeks to 10 April, prompting management to put out a statement in an attempt to reassure investors. 

IC TIP: Sell at 22p
This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in